Intellipharmaceutics (IPCI)
0.21 -0.06 (-22.00%) 03/20/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Mar 20th, 2019
Results
download Want to compare other data? Select Fields| Symbol | IPCI | NLSP | XBIO | ||
| Company | Intellipharmaceutics | Nls Pharmaceutics Ltd | Xenetic Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.22 | 1.5200 | 2.84 | ||
| High | 0.27 | 1.5200 | 2.84 | ||
| Low | 0.21 | 1.4600 | 2.68 | ||
| Last | 0.21 | 1.4720 | 2.84 | ||
| Change | -0.06 | -0.0530 | -0.02 | ||
| % Change | -22.00% | -3.48% | -0.70% | ||
| Volume | 2,368,700 | 5,400 | 1,100 | ||
| 20-Day Average Volume | 1,022,865 | 97,075 | 8,225 | ||
| Previous Close | 0.27 | 1.5250 | 2.86 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.28 | 1.4480 | 2.53 | ||
| 20-Day Raw Stochastic | 0.32% | 55.88% | 88.67% | ||
| 20-Day Relative Strength | 37.08% | 45.60% | 47.22% | ||
| Weighted Alpha | -87.59 | -78.89 | -42.36 | ||
| Today's Opinion | 100% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 48% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.09% since 03/13/19 | +0.14% since 04/23/25 | +11.37% since 04/23/25 | ||
| Low | 0.21 on 03/20/19 | 1.4100 on 04/29/25 | 2.47 on 04/24/25 | ||
| High | 0.28 on 03/18/19 | 1.5499 on 04/29/25 | 2.92 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | -44.58% since 02/20/19 | +13.23% since 03/28/25 | -8.97% since 03/28/25 | ||
| Low | 0.21 on 03/20/19 | 1.3100 on 04/08/25 | 2.20 on 04/07/25 | ||
| High | 0.40 on 02/21/19 | 1.5999 on 04/15/25 | 3.12 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -10.38% since 12/20/18 | -25.66% since 01/30/25 | -31.76% since 01/30/25 | ||
| Low | 0.21 on 03/20/19 | 1.3000 on 03/28/25 | 2.20 on 04/07/25 | ||
| High | 0.43 on 02/20/19 | 3.3700 on 01/31/25 | 4.32 on 02/10/25 | ||
| 6-Month | |||||
| %Chg | -92.37% since 09/20/18 | -61.87% since 10/30/24 | -33.64% since 10/30/24 | ||
| Low | 0.20 on 12/13/18 | 1.3000 on 03/28/25 | 2.20 on 04/07/25 | ||
| High | 4.10 on 09/24/18 | 4.7400 on 11/04/24 | 4.65 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,618 | 5,486 | 4,410 | ||
| Shares Outstanding, K | 21,926 | 3,598 | 1,542 | ||
| Annual Sales | 1,710,000 | 0 | 2,500,000 | ||
| Annual Net Income | -13,750,000 | -12,170,000 | -3,960,000 | ||
| Last Quarter Sales | 390,000 | N/A | 650,000 | ||
| Last Quarter Net Income | -3,780,000 | N/A | -1,050,000 | ||
| 60-Month Beta | 2.17 | -0.21 | 2.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.68 on 03/18/25 | ||
| Latest Earnings Date | 04/15/19 | 05/21/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||